Research Results

Dissemination of the research results of CLLassify.

Publications

1. N. Papakonstantinou, S. Ntoufa, E. Chartomatsidou, K. Kotta, A. Agathangelidis, L. Giassafaki, T. Karamanli, P. Bele, T. Moysiadis, P. Baliakas, L.A. Sutton, N. Stavroyianni, A. Anagnostopoulos, A.M. Makris, P. Ghia, R. Rosenquist and K. Stamatopoulos. The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemiaOncotarget 7, May 2016.


Conferences

1. T. Moysiadis, P. Baliakas, et al.

Poster title: “Redefining prognostication in chronic lymphocytic leukemia. A novel multidisciplinary approach integrating disease heterogeneity 

Marie Sklodowska-Curie Actions, ESOF satellite event ‘Research and society, in the University of Manchester, Manchester, United Kingdom, July 28-29, 2016.

 

2. T. Moysiadis, P. Baliakas, et al.

Poster title: Tailored Approaches for Refined Prognostication in Chronic Lymphocytic Leukemia Patients with Mutated Versus Unmutated Immunoglobulin Receptors

58th ASH Annual Meeting & Exposition, in the San Diego Convention Center, San Diego, CA, USA,  December 3-6, 2016.

 

3.  T. Moysiadis, P. Baliakas, et al.

Presentation title: Refining prognostication in CLL.

9th EMR-IBS and Italian Region conference , in the  MET Hotel, Thessaloniki, Greece, May 8-12, 2017.

 

4. T. Moysiadis, P. Baliakas, et al.,

Presentation title: Different Time-Dependent Risk for Disease Evolution in Chronic Lymphocytic Leukemia with Distinct IGHV Gene Somatic Hypermutation Status. 

28th Annual meeting of the Hellenic Society of Haematology, in the Megaro Mousikis, Athens, Greece, November 2-4, 2017.

 

5. T. Moysiadis, P. Baliakas, et al.

Poster title: Different Time-Dependent Risk for Disease Evolution in Chronic Lymphocytic Leukemia with Distinct IGHV Gene Somatic Hypermutation Status.

59th ASH Annual Meeting & Exposition, in the Georgia World Congress Center, Atlanta, GA, USA, December 9-12, 2017.

 

6. T. Moysiadis, P. Baliakas, et al.

Poster title: Different Risk Evolution for Chronic Lymphocytic Leukemia Progression with Distinct IGHV Gene Somatic Hypermutation Status.

5th MCAA Annual Conference and General Assembly, in the KU, Leuven, Belgium, February 2-3, 2018.